Vimarsana
Biggest News Aggregation in the World

Page 32 - Beigene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Today - Breaking & Trending Today

BeiGene Announces BRUKINSA (zanubrutinib) Is Approved in 50 Markets - Vimarsana News

BeiGene Announces BRUKINSA (zanubrutinib) Is Approved in 50 Markets

13.06.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced that its BTK ... Seite 1

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Quarterly Sales of $312.21 Million - Vimarsana News

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Quarterly Sales of $312.21 Million

Equities analysts expect that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will report $312.21 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for BeiGene’s earnings, with the lowest sales estimate coming in at $307.52 million and the highest estimate coming in at $316.90 million. BeiGene posted sales of $149.99 million […]

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Announce Earnings of -$4.38 Per Share - Vimarsana News

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Announce Earnings of -$4.38 Per Share

Wall Street brokerages predict that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will post ($4.38) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for BeiGene’s earnings, with the lowest EPS estimate coming in at ($4.45) and the highest estimate coming in at ($4.30). BeiGene reported […]

BeiGene, Ltd. (NASDAQ:BGNE) Receives Average Rating of "Buy" from Brokerages - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) Receives Average Rating of "Buy" from Brokerages

Shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating on the company. The […]

BeiGene, Ltd.: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland - Vimarsana News

BeiGene, Ltd.: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new